Orthofix Medical Net Income Over Time
| OFIX Stock | USD 13.13 0.01 0.08% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Orthofix Medical Performance and Orthofix Medical Correlation. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. Anticipated expansion of Orthofix directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Orthofix Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.03) | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets | Return On Equity |
Orthofix Medical's market price often diverges from its book value, the accounting figure shown on Orthofix's balance sheet. Smart investors calculate Orthofix Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Orthofix Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Orthofix Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Orthofix Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Orthofix Medical and related stocks such as Pacific Biosciences, Si Bone, and Varex Imaging Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PACB | (21.5 M) | (109.4 M) | (94.5 M) | (79.3 M) | (66.2 M) | (31.7 M) | (74.4 M) | (92.2 M) | (102.6 M) | (84.1 M) | 29.4 M | (181.2 M) | (314.2 M) | (306.7 M) | (309.9 M) | (278.9 M) | (264.9 M) |
| SIBN | (10.9 M) | (10.9 M) | (10.9 M) | (6.2 M) | (27.8 M) | (28.2 M) | (20.6 M) | (23 M) | (17.5 M) | (38.4 M) | (43.7 M) | (56.6 M) | (61.3 M) | (43.3 M) | (30.9 M) | (27.8 M) | (29.2 M) |
| VREX | 109.6 M | 109.6 M | 109.6 M | 110.1 M | 80 M | 68.5 M | 51.6 M | 27.5 M | 15.5 M | (57.9 M) | 17.4 M | 30.3 M | 48.2 M | (47.7 M) | (69.9 M) | (62.9 M) | (59.8 M) |
| BFLY | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (99.6 M) | (162.7 M) | (32.4 M) | (168.7 M) | (133.7 M) | (72.5 M) | (65.2 M) | (68.5 M) |
| AVNS | 142.4 M | 142.4 M | 152.6 M | 154.6 M | 27.1 M | (426.3 M) | 39.8 M | 79.3 M | 57.5 M | (45.9 M) | (27.2 M) | 6.3 M | 50.5 M | (61.8 M) | (392.1 M) | (352.9 M) | (335.2 M) |
| ABSI | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (14.4 M) | (101 M) | (104.9 M) | (110.6 M) | (103.1 M) | (92.8 M) | (97.4 M) |
| DRIO | (5.7 M) | (5.7 M) | (5.7 M) | (13.9 M) | (12.9 M) | (7.1 M) | (10.9 M) | (15.7 M) | (17.8 M) | (17.7 M) | (29.4 M) | (76.8 M) | (62.2 M) | (59.4 M) | (42.7 M) | (38.5 M) | (40.4 M) |
| MLTX | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (90.8 K) | (4.5 M) | (64.5 M) | (36 M) | (118.9 M) | (107 M) | (101.7 M) |
| LAB | (23.6 M) | (22.5 M) | (19 M) | (15.8 M) | (52.8 M) | (53.3 M) | (76 M) | (60.5 M) | (59 M) | (64.8 M) | (53 M) | (59.2 M) | (190.1 M) | (74.7 M) | (138.9 M) | (125 M) | (118.7 M) |
| ESPR | (10.7 M) | (10.8 M) | (11.7 M) | (26.1 M) | (36.4 M) | (49.8 M) | (75 M) | (167 M) | (201.8 M) | (97.2 M) | (143.6 M) | (269.1 M) | (233.7 M) | (209.2 M) | (51.7 M) | (46.6 M) | (48.9 M) |
Orthofix Medical and related stocks such as Pacific Biosciences, Si Bone, and Varex Imaging Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Orthofix Medical financial statement analysis. It represents the amount of money remaining after all of Orthofix Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Orthofix Medical | OFIX |
| Classification | Obamacare |
| Business Address | 3451 Plano Parkway, |
| Exchange | NASDAQ Exchange |
USD 13.13
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.